EudociaQuant(Quant)LeeMD

Oncology • Boston, MA

Neuro-Oncology

Physician

Join to view full profile

Dr. Lee is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Lee's full profile

Already have an account?

Office
450 Brookline Avenue
Dana Farber Cancer Insitute
Boston, MA 02115
Phone+1 617-632-2166

Fax+1 617-632-4773

Education & Training

Beth Israel Deaconess Medical CenterInternship, Internal Medicine, 2003 - 2004
Washington University in St. Louis School of MedicineClass of 2003

Certifications & Licensure

MA State Medical License 2007 - 2026
ME State Medical License 2022 - 2026
NH State Medical License 2022 - 2026
VT State Medical License 2022 - 2026
RI State Medical License 2020 - 2020
American Board of Psychiatry and Neurology Neurology

Clinical Trials

A Randomized Placebo-Controlled Trial of Armodafinil (Nuvigil) for Fatigue in Patients With Malignant Gliomas Start of enrollment: 2008 Sep 01
Completed
Phase 2
Sapanisertib Before and After Surgery in Treating Patients With Recurrent Glioblastoma Start of enrollment: 2014 Jul 02
Terminated
Phase 1
A Pilot Study to Evaluate PBR PET in Brain Tumor Patients Treated With Chemoradiation or Immunotherapy Start of enrollment: 2015 May 01
Completed
Not Applicable
Trial of Ponatinib in Patients With Bevacizumab-Refractory Glioblastoma Start of enrollment: 2015 Jul 13
Completed
Phase 2
Pembrolizumab In Central Nervous System Metastases Start of enrollment: 2016 Oct 01
Active, not recruiting
Phase 2
Phase II Trial of Pembrolizumab in Recurrent or Residual High Grade Meningioma Start of enrollment: 2017 Nov 07
Active, not recruiting
Phase 2
Niraparib in Tumors Metastatic to the CNS Start of enrollment: 2022 Apr 05
Recruiting
Phase 2
Roles: Contact, Principal Investigator
A Study of Abemaciclib in Recurrent Glioblastoma Start of enrollment: 2017 Feb 09
Active, not recruiting
Phase 2
Roles: Principal Investigator
Join now to see all

Publications & Presentations

PubMed

Assay for the quantification of abemaciclib, its metabolites, and olaparib in human plasma by liquid chromatography-tandem mass spectrometry.
Kasey L Hill, Nicole L Abbott, Joo Young Na, Michelle Rudek, Kathleen Moore
Journal of Pharmaceutical and Biomedical Analysis. 2025-01-15
4 citations
Leptomeningeal metastases from solid tumors: A Society for Neuro-Oncology and American Society of Clinical Oncology consensus review on clinical management and future ...
Jessica A Wilcox, Ugonma N Chukwueke, Myung-Ju Ahn, Ayal A Aizer, Tejus A Bale
Neuro-Oncology. 2024-10-03
1 citations
Burnout and career satisfaction in young neuro-oncology investigators: Results of the Society for Neuro-Oncology Young Investigator Survey.
Gilbert Youssef, Alvina Acquaye-Mallory, Elizabeth Vera, Milan G Chheda, Gavin P Dunn
Neuro-Oncology Practice. 2024-08-01

Lectures

Barriers to accrual and enrollment in brain tumor trials.
2019 ASCO Annual Meeting - 6/1/2019

Other

Anticoagulant and antiplatelet therapy in patients with brain tumors
Lee EQ, Wen PY
http://www.uptodate.com/contents/anticoagulant-and-antiplatelet-therapy-in-patients-with-brain-tumor
UpToDate, Wolters Kluwer Health - 2013-02-22
Neurologic complications of cancer treatment with biologic agents
Lee EQ, Wen PY
http://www.uptodate.com/contents/neurologic-complications-of-cancer-treatment-with-biologic-agents
UpToDate, Wolters Kluwer Health - 2013-02-25
Neurologic complications of non-platinum cancer chemotherapy
Lee EQ, Wen PY
http://www.uptodate.com/contents/neurologic-complications-of-non-platinum-cancer-chemotherapy
UpToDate, Wolters Kluwer Health - 2013-03-19
Neurologic complications of platinum-based chemotherapy
Lee EQ, Wen PY
http://www.uptodate.com/contents/neurologic-complications-of-platinum-based-chemotherapy
UpToDate, Wolters Kluwer Health - 2012-12-21
Join now to see all

Press Mentions

Kazia Executes Agreement to Commence GBM Agile Pivotal StudyOctober 16th, 2020
Kazia Therapeutics Executes Agreement to Begin GBM Agile Pivotal StudyOctober 15th, 2020